I. Kaplan

发表

Cationic TAT peptide transduction domain enters cells by macropinocytosis.

Steven F Dowdy, S. Dowdy, J. Wadia, 2005, Journal of controlled release : official journal of the Controlled Release Society.

A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2

Jennifer N. Dines, Massimiliano Mazza, Giovanni Martinelli, 2020, Research square.

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

Damon H. May, J. Heath, L. Notarangelo, 2020, medRxiv.

Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model

R. Hollingsworth, G. Merlino, T. van Dyke, 2021, Molecular Cancer Research.

T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity

T. Snyder, J. Carlson, H. Robins, 2021, medRxiv.

The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders

D. McGovern, Dalin Li, R. Gittelman, 2021, medRxiv.

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

H. Schuitemaker, R. Baric, M. Lifton, 2021, Nature.

Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

J. Lünemann, R. Hohlfeld, H. Wiendl, 2022, The Journal of experimental medicine.

Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.

R. Cox, K. Brokstad, Fan Zhou, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Deep immune profiling reveals early-stage and highly coordinated immune responses in mild COVID-19 patients

C. Carty, F. Betsou, M. Vaillant, 2021, medRxiv.

Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection

T. Snyder, J. N. Dines, R. Gittelman, 2021, medRxiv.

FLT3-ITD Knock-in Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to a Myeloproliferative Neoplasm

C. Civin, D. Huso, D. Small, 2011 .

Durable immune responses after BNT162b2 vaccination in home-dwelling old adults

R. Cox, K. Brokstad, Fan Zhou, 2023, Vaccine: X.

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

M. Askenazi, L. Notarangelo, S. Holland, 2022, Nature Medicine.

Multi-omics approach identifies novel age-, time- and treatment-related immunopathological signatures in MIS-C and pediatric COVID-19

Andrew J. Oler, U. Mudunuri, M. Askenazi, 2021, medRxiv.

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.

G. Giaccone, Chul Kim, M. Tan, 2018, The Lancet. Oncology.

Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo1

M. McDevitt, C. Civin, Xiaobing Yu, 2007, The Journal of Immunology.

FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.

C. Civin, D. Huso, D. Small, 2012, Cell stem cell.

Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors

Elias T. Zambidis, Ann Peters, T. Park, 2012, PloS one.

C. Civin, D. Small, B. Godsey, 2014, PloS one.

Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo 1

M. McDevitt, C. Civin, Xiaobing Yu, 2008 .

Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients

C. Carty, P. Wilmes, A. del Sol, 2022, Cell Reports Medicine.

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease

D. McGovern, Dalin Li, R. Gittelman, 2022, Frontiers in Immunology.

LB17. Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease

Alison W. Rebman, R. Emerson, T. Snyder, 2021, medRxiv.

Characterisation of T cell receptor repertoires in coeliac disease

R. Emerson, G. Bhagat, D. Williamson, 2022, Journal of clinical pathology.

Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo.

M. McDevitt, C. Civin, Xiaobing Yu, 2007 .

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

D. McGovern, Dalin Li, R. Gittelman, 2022, Inflammatory bowel diseases.

Deletion of Tristetraprolin Caused Spontaneous Reactive Granulopoiesis by a Non–Cell-Autonomous Mechanism Without Disturbing Long-Term Hematopoietic Stem Cell Quiescence

C. Civin, Wen-Chih Cheng, I. Kaplan, 2011, The Journal of Immunology.

Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides.

E. Snyder, S. Dowdy, X. Cui, 2005, Cancer research.

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias

P. Meltzer, S. Davis, R. Walker, 2010, Leukemia.

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity

Damon H. May, T. Snyder, J. Carlson, 2022, JCI insight.

Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

R. Cox, K. Brokstad, Fan Zhou, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Corrigendum to “Cationic TAT peptide transduction domain enters cells by macropinocytosis” [J. Control. Release 102 (2005) 247–253]

S. Dowdy, J. Wadia, I. Kaplan, 2005 .

Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals.

Andrew J. Oler, K. Dobbs, T. Snyder, 2023, The Journal of allergy and clinical immunology.